Medable Achieves 75% eConsent Adoption Across Elderly Patients in Pivotal U.S. Renal Care Clinical Trial
Digital Health Global
APRIL 16, 2024
The Phase IV trial, funded by a top-10 global pharmaceutical company, had a narrow recruitment window to enroll patients suffering from Anemia in End Stage Kidney Disease (ESKD) across more than 40 dialysis centers, involving 476 site users. .–(BUSINESS WIRE)– Medable Inc. , Renal Care ’s (USRC) investigator-initiated trial.
Let's personalize your content